IRIS
BOCCUTO, ADELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.706
EU - Europa 2.610
AS - Asia 1.051
SA - Sud America 217
Continente sconosciuto - Info sul continente non disponibili 138
AF - Africa 71
OC - Oceania 4
Totale 6.797
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.648
RU - Federazione Russa 612
IT - Italia 553
GB - Regno Unito 482
SG - Singapore 321
IE - Irlanda 306
CN - Cina 257
BR - Brasile 186
SE - Svezia 156
FR - Francia 137
DE - Germania 136
HK - Hong Kong 120
VN - Vietnam 111
IN - India 70
FI - Finlandia 54
UA - Ucraina 47
ES - Italia 35
ZA - Sudafrica 35
BD - Bangladesh 28
CA - Canada 28
KR - Corea 28
JP - Giappone 24
TR - Turchia 23
MX - Messico 18
BE - Belgio 16
PL - Polonia 15
NG - Nigeria 13
AR - Argentina 12
NL - Olanda 11
MA - Marocco 10
UZ - Uzbekistan 10
IQ - Iraq 9
IR - Iran 9
AT - Austria 7
CZ - Repubblica Ceca 6
GR - Grecia 6
ID - Indonesia 5
JM - Giamaica 5
PK - Pakistan 5
CO - Colombia 4
DK - Danimarca 4
EC - Ecuador 4
EG - Egitto 4
LV - Lettonia 4
PT - Portogallo 4
PY - Paraguay 4
RO - Romania 4
CI - Costa d'Avorio 3
HN - Honduras 3
JO - Giordania 3
RS - Serbia 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 6.660
Salva come PNG Salva come JPEG
Città #
Southend 410
Dublin 303
Dallas 302
Fairfield 221
Chandler 198
Ashburn 181
Moscow 179
Singapore 175
San Jose 166
Santa Clara 155
Hong Kong 111
Siena 111
Milan 108
Beijing 101
Seattle 84
Woodbridge 80
Houston 73
Council Bluffs 72
Ann Arbor 71
Cambridge 71
Wilmington 61
Rome 59
Princeton 54
New York 53
Munich 52
Ho Chi Minh City 45
Los Angeles 45
Lauterbourg 41
Jacksonville 40
Johannesburg 34
Helsinki 32
Hefei 29
The Dalles 29
Seoul 25
São Paulo 24
Boardman 22
Málaga 22
Bengaluru 21
Tokyo 20
Hanoi 18
Portsmouth 17
Brussels 16
San Mateo 16
Frankfurt am Main 15
San Diego 15
Orem 14
Shanghai 14
Abuja 13
Buffalo 13
London 13
Redondo Beach 13
Dearborn 12
Florence 11
Warsaw 11
Brescia 10
Columbus 10
Düsseldorf 10
Lappeenranta 10
Montreal 10
Redwood City 10
Figino 9
Fremont 9
Manchester 9
Mexico City 9
Naples 9
Nuremberg 9
Turku 9
Nanjing 8
Atlanta 7
Brooklyn 7
Chennai 7
Dong Ket 7
Izmir 7
Paris 7
Phoenix 7
Rio de Janeiro 7
Roccagorga 7
Tashkent 7
Toronto 7
Belo Horizonte 6
Indianapolis 6
Mumbai 6
North Bergen 6
Tucson 6
Vienna 6
Andover 5
Brasília 5
Denver 5
Haiphong 5
Perugia 5
San Francisco 5
Zanjan 5
Amsterdam 4
Bangalore 4
Barnet 4
Cagliari 4
Cairo 4
Changsha 4
Copenhagen 4
Da Nang 4
Totale 4.402
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 335
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 308
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 304
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 303
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 299
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 267
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 262
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 257
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 257
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 254
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 242
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 235
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 231
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 217
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 211
Novel antiviral strategies against emerging viral diseases 206
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 192
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 190
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 188
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 186
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 165
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 154
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 146
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 146
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis 144
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 144
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 144
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 142
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 137
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 129
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 126
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 120
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 68
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 56
null 32
Totale 6.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022676 0 86 57 88 43 46 43 47 34 57 61 114
2022/2023613 41 98 71 60 46 103 32 38 49 34 25 16
2023/2024521 18 17 48 31 5 147 168 10 0 15 12 50
2024/20251.087 28 40 157 51 110 77 41 90 113 69 110 201
2025/20262.521 150 293 249 348 547 86 256 79 86 159 80 188
2026/2027129 85 44 0 0 0 0 0 0 0 0 0 0
Totale 6.797